| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() Hepatitis B Injection Approved for Treating Acute Exposure NEW YORK -- April 23, 2009 -- Health Canada has approved the hepatitis B immune globulin (human) injection (HepaGam B) for treating acute exposure to hepatitis B virus (HBV). Specifically, the approval is for post-exposure prophylaxis (PEP) for acute exposure to blood containing hepatitis B surface antigen (HBsAg), perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons, and household exposure to persons with acute hepatitis B infection. The most common expected adverse drug reactions for intravenous immune SOURCE: Cangene
|